Table 1.
Variable | All (N = 263) |
---|---|
Age, median (range) | 64 (19–84) |
Sex | |
Male | 157 (60%) |
Female | 106 (40%) |
ECOG | |
0 | 98 (37%) |
≥1 | 165 (63%) |
Stage | |
Locally advanced | 37 (14%) |
Metastatic | 226 (86%) |
Chemotherapy | |
FOLFIRINOX | 143 (54%) |
Gemcitabine and nab-paclitaxel | 98 (37%) |
Other | 7 (3%) |
None | 15 (6%) |
Moffitt subtype | |
Classical | 198 (80%) |
Basal-like | 49 (20%) |
HRDetect | |
>0.7 | 31 (13%) |